![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 19, 16411-16417, May 11, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the There is ample evidence that deregulation of
apoptosis results in the development, progression, and/or maintenance
of cancer. Since many apoptotic regulatory genes (e.g.
bcl-x) code for alternatively spliced protein variants with
opposing functions, the manipulation of alternative splicing presents a
unique way of regulating the apoptotic response. Here we have targeted
oligonucleotides antisense to the 5'-splice site of
bcl-xL, an anti-apoptotic gene that is
overexpressed in various cancers, and shifted the splicing pattern of
Bcl-x pre-mRNA from Bcl-xL to Bcl-xS, a
pro-apoptotic splice variant. This approach induced significant
apoptosis in PC-3 prostate cancer cells. In contrast, the same
oligonucleotide treatment elicited a much weaker apoptotic response in
MCF-7 breast cancer cells. Moreover, although the shift in Bcl-x
pre-mRNA splicing inhibited colony formation in both cell lines,
this effect was much less pronounced in MCF-7 cells. These differences
in responses to oligonucleotide treatment were analyzed in the context
of expression of Bcl-xL, Bcl-xS, and Bcl-2
proteins. The results indicate that despite the presence of Bcl-x
pre-mRNA in a number of cell types, the effects of modification of
its splicing by antisense oligonucleotides vary depending on the
expression profile of the treated cells.
Modification of Alternative Splicing of Bcl-x
Pre-mRNA in Prostate and Breast Cancer Cells
ANALYSIS OF APOPTOSIS AND CELL DEATH*
,
¶
Lineberger Comprehensive Cancer Center and
the Department of Pharmacology, University of North Carolina, Chapel
Hill, North Carolina 27599-7295 and the § Laboratory of
Signal Transduction, NIEHS, National Institutes of Health,
Research Triangle Park, North Carolina 27709
*
This work was supported in part by Grants PO1-59299 and
HL-51940-05 from the National Institutes of Health (to R. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
Y. Hai, W. Cao, G. Liu, S.-P. Hong, S. A. Elela, R. Klinck, J. Chu, and J. Xie A G-tract element in apoptotic agents-induced alternative splicing Nucleic Acids Res., June 1, 2008; 36(10): 3320 - 3331. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shkreta, U. Froehlich, E. R. Paquet, J. Toutant, S. A. Elela, and B. Chabot Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes Mol. Cancer Ther., June 1, 2008; 7(6): 1398 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kuraoka, S. Ito, T. Wada, M. Hayashida, L. Lee, M. Saijo, Y. Nakatsu, M. Matsumoto, T. Matsunaga, H. Handa, et al. Isolation of XAB2 Complex Involved in Pre-mRNA Splicing, Transcription, and Transcription-coupled Repair J. Biol. Chem., January 11, 2008; 283(2): 940 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, J. J. Peairs, P. Yang, J. Tyrrell, J. Roberts, R. Kole, and G. J. Jaffe The Importance of Bcl-xL in the Survival of Human RPE Cells Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3846 - 3853. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frank, J. L. Bermejo, K. Hemminki, C. Sutter, B. Wappenschmidt, A. Meindl, M. Kiechle-Bahat, P. Bugert, R. K. Schmutzler, C. R. Bartram, et al. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk Carcinogenesis, July 1, 2007; 28(7): 1442 - 1445. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Du, J. M. Pollard, and R. A. Gatti Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides PNAS, April 3, 2007; 104(14): 6007 - 6012. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hayes, P. E. Carrigan, and L. J. Miller Serine-Arginine Protein Kinase 1 Overexpression Is Associated with Tumorigenic Imbalance in Mitogen-Activated Protein Kinase Pathways in Breast, Colonic, and Pancreatic Carcinomas Cancer Res., March 1, 2007; 67(5): 2072 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Jenkins, A. Swiatoniowski, M. R. Power, and T.-J. Lin Pseudomonas aeruginosa-Induced Human Mast Cell Apoptosis Is Associated with Up-Regulation of Endogenous Bcl-xS and Down-Regulation of Bcl-xL J. Immunol., December 1, 2006; 177(11): 8000 - 8007. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Massiello, J. R. Roesser, and C. E. Chalfant SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA FASEB J, August 1, 2006; 20(10): 1680 - 1682. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Watermann, Y. Tang, A. zur Hausen, M. Jager, S. Stamm, and E. Stickeler Splicing Factor Tra2-{beta}1 Is Specifically Induced in Breast Cancer and Regulates Alternative Splicing of the CD44 Gene. Cancer Res., May 1, 2006; 66(9): 4774 - 4780. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Komuro, T. Yasuda, A. Iwamoto, and K. S. Akagawa Catalase Plays a Critical Role in the CSF-independent Survival of Human Macrophages via Regulation of the Expression of BCL-2 Family J. Biol. Chem., December 16, 2005; 280(50): 41137 - 41145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Wilusz, S. C. Devanney, and M. Caputi Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo Nucleic Acids Res., November 18, 2005; 33(20): 6547 - 6554. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garneau, T. Revil, J.-F. Fisette, and B. Chabot Heterogeneous Nuclear Ribonucleoprotein F/H Proteins Modulate the Alternative Splicing of the Apoptotic Mediator Bcl-x J. Biol. Chem., June 17, 2005; 280(24): 22641 - 22650. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shangary, C. L. Oliver, T. S. Tillman, M. Cascio, and D. E. Johnson Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides Mol. Cancer Ther., November 1, 2004; 3(11): 1343 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G. Bruno, W. Jin, and G. J. Cote Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements Hum. Mol. Genet., October 1, 2004; 13(20): 2409 - 2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Massiello, A. Salas, R. L. Pinkerman, P. Roddy, J. R. Roesser, and C. E. Chalfant Identification of Two RNA cis-Elements That Function to Regulate the 5' Splice Site Selection of Bcl-x Pre-mRNA in Response to Ceramide J. Biol. Chem., April 16, 2004; 279(16): 15799 - 15804. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ittig, S. Liu, D. Renneberg, D. Schumperli, and C. J. Leumann Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA Nucleic Acids Res., January 15, 2004; 32(1): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Villemaire, I. Dion, S. A. Elela, and B. Chabot Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides J. Biol. Chem., December 12, 2003; 278(50): 50031 - 50039. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Vacek, H. Ma, F. Gemignani, G. Lacerra, T. Kafri, and R. Kole High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA Blood, January 1, 2003; 101(1): 104 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Mercatante, J. L. Mohler, and R. Kole Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gemignani, P. Sazani, P. Morcos, and R. Kole Temperature-dependent splicing of {beta}-globin pre-mRNA Nucleic Acids Res., November 1, 2002; 30(21): 4592 - 4598. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Chalfant, K. Rathman, R. L. Pinkerman, R. E. Wood, L. M. Obeid, B. Ogretmen, and Y. A. Hannun De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells. DEPENDENCE ON PROTEIN PHOSPHATASE-1 J. Biol. Chem., April 5, 2002; 277(15): 12587 - 12595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lim and K. J. Hertel Modulation of Survival Motor Neuron Pre-mRNA Splicing by Inhibition of Alternative 3' Splice Site Pairing J. Biol. Chem., November 21, 2001; 276(48): 45476 - 45483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |